Map for MDOverslag post-neoadjuvant en pre-operatief / gemetastaseerde ziekte (M1)

Concept DECOR id DECOR effectiveDate FHIR id FHIR definition FHIR type
Demografische gegevens 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.1 2017-03-30T15:30:34 onco-generic-dataelement-1 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-1 group
Patiƫnt 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.2 2017-03-30T15:30:34 onco-generic-dataelement-2 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-2 group
Naamgegevens 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.3 2017-03-30T15:30:34 NL-CM-0.1.6 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.6 group
Initialen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.4 2017-03-30T15:30:34 NL-CM-0.1.35 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.35 string
Geslachtsnaam 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.5 2017-03-30T15:30:34 NL-CM-0.1.36 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.36 group
Achternaam 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.6 2017-03-30T15:30:34 NL-CM-0.1.24 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.24 string
PatientIdentificatienummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.7 2017-03-30T15:30:34 NL-CM-0.1.7 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.7 string
Geboortedatum 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.8 2017-03-30T15:30:34 NL-CM-0.1.10 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.10 dateTime
Geslacht 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.9 2017-03-30T15:30:34 NL-CM-0.1.9 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.9 choice
Zorgaanbieder 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.10 2017-03-30T15:30:34 NL-CM-17.2.1 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.1 group
ZorgaanbiederIdentificatieNummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.11 2017-03-30T15:30:34 NL-CM-17.2.2 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.2 string
OrganisatieNaam 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.12 2017-03-30T15:30:34 NL-CM-17.2.3 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.3 string
AfdelingSpecialisme 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.13 2017-03-30T15:30:34 NL-CM-17.2.7 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.7 choice
TelefoonEmail 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.14 2017-03-30T15:30:34 NL-CM-17.2.6 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.6 group
Contactgegevens 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.15 2017-03-30T15:30:34 zib1bbr-dataelement-3414 http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3414 group
Telefoonnummers 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.16 2017-03-30T15:30:34 zib1bbr-dataelement-3415 http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3415 group
Telefoonnummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.17 2017-03-30T15:30:34 NL-CM-0.1.23 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.23 string
NummerSoort 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.18 2017-03-30T15:30:34 NL-CM-0.1.22 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.22 choice
EmailAdressen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.19 2017-03-30T15:30:34 zib1bbr-dataelement-3418 http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3418 group
EmailAdres 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.20 2017-03-30T15:30:34 NL-CM-0.1.20 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.20 string
EmailSoort 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.21 2017-03-30T15:30:34 NL-CM-0.1.19 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.19 choice
Adres 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.22 2017-03-30T15:30:34 NL-CM-17.2.5 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.5 group
Adresgegevens 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.23 2017-03-30T15:30:34 zib1bbr-dataelement-3421 http://www.iknl.nl/fhir/DataElement/zib1bbr-dataelement-3421 group
Straat 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.24 2017-03-30T15:30:34 NL-CM-0.1.12 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.12 string
Huisnummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.25 2017-03-30T15:30:34 NL-CM-0.1.13 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.13 string
Huisnummerletter 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.26 2017-03-30T15:30:34 NL-CM-0.1.40 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.40 string
Huisnummertoevoeging 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.27 2017-03-30T15:30:34 NL-CM-0.1.41 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.41 string
AanduidingBijNummer 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.28 2017-03-30T15:30:34 NL-CM-0.1.42 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.42 choice
Postcode 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.29 2017-03-30T15:30:34 NL-CM-0.1.15 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.15 string
Woonplaats 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.30 2017-03-30T15:30:34 NL-CM-0.1.14 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.14 string
Gemeente 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.31 2017-03-30T15:30:34 NL-CM-0.1.16 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.16 string
Land 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.32 2017-03-30T15:30:34 NL-CM-0.1.17 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.17 choice
AdditioneleInformatie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.33 2017-03-30T15:30:34 NL-CM-0.1.28 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.28 string
AdresSoort 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.34 2017-03-30T15:30:34 NL-CM-0.1.11 http://www.iknl.nl/fhir/DataElement/NL-CM-0.1.11 choice
OrganisatieType 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.35 2017-03-30T15:30:34 NL-CM-17.2.4 http://www.iknl.nl/fhir/DataElement/NL-CM-17.2.4 choice
Aanvullend onderzoek 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.62 2017-03-30T15:30:34 onco-generic-dataelement-81 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-81 group
Radiologie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.171 2017-03-30T15:30:34 onco-generic-dataelement-127 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-127 group
MRI 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.191 2017-03-30T15:30:34 onco-generic-dataelement-145 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-145 group
MRI borst 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.192 2017-03-30T15:30:34 onco-mamma-dataelement-192 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-192 group
Laesie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.197 2017-03-30T15:30:34 onco-mamma-dataelement-197 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-197 group
Diameter 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.200 2017-03-30T15:30:34 onco-mamma-dataelement-200 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-200 quantity
Zijdigheid 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.201 2017-03-30T15:30:34 onco-mamma-dataelement-201 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-201 choice
Lokalisatie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.202 2017-03-30T15:30:34 onco-mamma-dataelement-202 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-202 choice
Respons 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.203 2017-03-30T15:30:34 onco-mamma-dataelement-203 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-203 choice
Multidisciplinair overleg 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.224 2017-03-30T15:30:34 onco-generic-dataelement-154 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-154 group
Datum MDO-verslag akkoord 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.225 2017-03-30T15:30:34 onco-generic-dataelement-155 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-155 date
Vraagstelling 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.226 2017-03-30T15:30:34 onco-generic-dataelement-156 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-156 string
Aanwezigheid: specialismen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.227 2017-03-30T15:30:34 onco-generic-dataelement-157 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-157 choice
MDO-verslag akkoord 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.228 2017-03-30T15:30:34 onco-generic-dataelement-159 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-159 choice
Datum 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.229 2017-03-30T15:30:34 onco-generic-dataelement-160 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-160 date
Diagnose en stadiƫring 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.230 2017-03-30T15:30:34 onco-generic-dataelement-161 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-161 group
Mammacarcinoom 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.231 2017-03-30T15:30:34 onco-mamma-dataelement-231 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-231 group
Post-neoadjuvant Preoperatief (ycTNM) / Gemetastaseerde ziekte (M1) 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.275 2017-03-30T15:30:34 onco-mamma-dataelement-275 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-275 group
Tumor 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.276 2017-03-30T15:30:34 onco-mamma-dataelement-276 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-276 group
Zijdigheid 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.277 2017-03-30T15:30:34 onco-mamma-dataelement-277 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-277 choice
Lokalisatie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.278 2017-03-30T15:30:34 onco-mamma-dataelement-278 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-278 choice
Respons primaire tumor 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.279 2017-03-30T15:30:34 onco-mamma-dataelement-279 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-279 choice
Calcificaties in borst 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.280 2017-03-30T15:30:34 onco-mamma-dataelement-280 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-280 choice
Distributie calcificaties in borst 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.281 2017-03-30T15:30:34 onco-mamma-dataelement-281 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-281 choice
ycT-diameter 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.282 2017-03-30T15:30:34 onco-mamma-dataelement-282 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-282 quantity
ycT4-kenmerken 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.283 2017-03-30T15:30:34 onco-mamma-dataelement-283 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-283 choice
Morfologie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.284 2017-03-30T15:30:34 onco-mamma-dataelement-284 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-284 choice
Graad 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.285 2017-03-30T15:30:34 onco-mamma-dataelement-285 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-285 choice
ycT 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.286 2017-03-30T15:30:34 onco-mamma-dataelement-286 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-286 choice
Lymfeklieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.287 2017-03-30T15:30:34 onco-mamma-dataelement-287 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-287 group
Zijdigheid 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.288 2017-03-30T15:30:34 onco-mamma-dataelement-288 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-288 choice
Gefixeerde axillaire klieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.289 2017-03-30T15:30:34 onco-mamma-dataelement-289 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-289 choice
Positieve axillaire klieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.290 2017-03-30T15:30:34 onco-mamma-dataelement-290 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-290 choice
Positieve parasternale klieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.291 2017-03-30T15:30:34 onco-mamma-dataelement-291 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-291 choice
Positieve infraclaviculaire klieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.292 2017-03-30T15:30:34 onco-mamma-dataelement-292 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-292 choice
Positieve supraclaviculaire klieren 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.293 2017-03-30T15:30:34 onco-mamma-dataelement-293 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-293 choice
ycN 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.294 2017-03-30T15:30:34 onco-mamma-dataelement-294 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-294 choice
Metastasen 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.295 2017-03-30T15:30:34 onco-mamma-dataelement-295 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-295 group
Respons systemische therapie bij gemetastaseerde ziekte 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.296 2017-03-30T15:30:34 onco-mamma-dataelement-296 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-296 choice
Lokalisatie metastase 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.297 2017-03-30T15:30:34 onco-mamma-dataelement-297 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-297 choice
ycM 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.298 2017-03-30T15:30:34 onco-mamma-dataelement-298 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-298 choice
ycTNM 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.299 2017-03-30T15:30:34 onco-mamma-dataelement-299 http://www.iknl.nl/fhir/DataElement/onco-mamma-dataelement-299 choice
Beleid 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.382 2017-03-30T15:30:34 onco-generic-dataelement-163 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-163 group
Advies klinische studie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.414 2017-03-30T15:30:34 onco-generic-dataelement-164 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-164 choice
Klinische studie 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.415 2017-03-30T15:30:34 onco-generic-dataelement-165 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-165 string
Beleid 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.416 2017-03-30T15:30:34 onco-generic-dataelement-166 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-166 string
Motivatie afwijken richtlijn 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.417 2017-03-30T15:30:34 onco-generic-dataelement-168 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-168 choice
Motivatie afwijken richtlijn anders 2.16.840.1.113883.2.4.3.11.31.1.77.2.2.418 2017-03-30T15:30:34 onco-generic-dataelement-169 http://www.iknl.nl/fhir/DataElement/onco-generic-dataelement-169 string